Coya Therapeutics, Inc. (COYA) Financials

COYA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 47.3 billion 4.0 billion
March 31, 2026 53.3 million 4.3 million
Dec. 31, 2025 50.0 million 6.9 million
Sept. 30, 2025 32.0 million 4.8 million

COYA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -13.7 billion 3.1 billion
March 31, 2026 -6.2 million 2.2 million
Dec. 31, 2025 -1.0 million 1.1 million
Sept. 30, 2025 -1.1 million 1.1 million

COYA Net Income

No data available :(

COYA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 43.2 billion - -
March 31, 2026 50.7 million - -
Dec. 31, 2025 46.8 million - -
Sept. 30, 2025 28.1 million - -

COYA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 23.5 million
March 31, 2026 22.6 million
Dec. 31, 2025 16.7 million
Sept. 30, 2025 16.7 million

COYA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 885000 5.0 million 2.3 million -
March 31, 2026 - 4.1 million 3.8 million -
Dec. 31, 2025 3 6.7 million 3.3 million -
Sept. 30, 2025 3 2.9 million 2.6 million -

COYA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 243745 -
March 31, 2026 251147 2807
Dec. 31, 2025 4.0 million -5.2 million
Sept. 30, 2025 3.6 million 6840

COYA

Price: $4.38

52 week price:
3.71
7.75

Earnings Per Share: -1.09 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Market Capitalization: 107.7 million

Links: